Adjuvant Immune Checkpoint Inhibition in Muscle-invasive Bladder Cancer: Is It Ready for Prime Time?
Adi Kartolo, Wassim Kassouf, Francisco Vera-Badillo
Topics & Concepts
MedicineAtezolizumabNivolumabBladder cancerAdjuvantOncologyInternal medicineChemotherapyNeoadjuvant therapyImmunotherapyAdjuvant chemotherapyCancerUrologyBreast cancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesCancer Immunotherapy and Biomarkers